Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Pretax Margin % is 4.38% as of Feb. 2026, which is 1% below its 10-year median of 4.44. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $51.79 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 50.3% on this metric.
The historical rank and industry rank for COSMOS Pharmaceutical's Pretax Margin % or its related term are showing as below:
CSMYF'
s Pretax Margin % Range Over the Past 10 Years
Min: 3.49 Med: 4.44 Max: 5.31
Current: 4
CSMYF's Pretax Margin % is ranked worse than 50.3% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.015
vs CSMYF: 4.00
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
COSMOS Pharmaceutical Pretax Margin % Related Terms
COSMOS Pharmaceutical Pretax Margin % Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Pretax Margin % of 4.38% as of Feb. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on COSMOS Pharmaceutical and its competitors. This is near median its historical median of 4.44. Over the past decade, COSMOS Pharmaceutical's Pretax Margin % has ranged from 3.49 to 5.31. According to the industry distribution chart, COSMOS Pharmaceutical ranks #334 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 50.3%.
Is COSMOS Pharmaceutical's Pretax Margin % too high?
COSMOS Pharmaceutical's current Pretax Margin % of 4.38% is near median its 10-year median of 4.44. Over the past 10 years, this metric has ranged from a low of 3.49 to a high of 5.31. The Healthcare Providers & Services industry median Pretax Margin % is 4.02. COSMOS Pharmaceutical's value of 4.38% is 9.1% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #334 out of 664 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Pretax Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #334 out of 664 companies for Pretax Margin %. This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Pretax Margin % is 4.02. COSMOS Pharmaceutical's value of 4.38% is 9.1% above this benchmark. Historically, COSMOS Pharmaceutical's own Pretax Margin % has ranged from 3.49 to 5.31 over the past decade. While the company's 10-year median is 4.44 vs. the industry median of 4.02, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Pretax Margin % of 4.38% is 9.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Pretax Margin % is 4.38%, which is near median its own 10-year median of 4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $51.79, compared to a current price of $37.06 — trading 28.4% below its estimated fair value. The current Pretax Margin % is 4.38%, which is near median its 10-year median of 4.44 and 9.1% above the Healthcare Providers & Services industry median of 4.02. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Pretax Margin % is 4.38% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 28.4% below its estimated GF Value™ of $51.79.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Pretax Margin %: 4.38% (near median its 10-year median of 4.44)
GF Value™: $51.79 vs. price of $37.06 (28.4% below fair value)
Industry Position: 9.1% above the Healthcare Providers & Services median (#334 of 664)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
